Results 31 to 40 of about 11,244,578 (287)

Analysis of the Normalized Sign-Sign LMS Algorithm

open access: yes, 2021
This work repots results of the convergence analysis of the normalized sign-sign least mean square (NSSLMS) algorithm when the input is real-valued data.
Zerguine, A.   +3 more
core   +1 more source

Enhancing Surgical Outcomes: Evaluating the Impact of Implementing the World Health Organization Surgical Safety Checklist—A Prospective Cross-Sectional Study

open access: yesThe Surgery Journal
Background Globally, surgical care plays a vital role in health care. Unfortunately, complications arise in approximately 5 to 18% of surgical procedures. However, research has shown that following the surgical safety checklist provided by the
ElMuhtadi B. Y. Gasoma   +1 more
doaj   +1 more source

ANALISIS KESESUAIAN PENERAPAN SAFETY SIGN DI PT. TERMINAL PETIKEMAS SURABAYA

open access: yesThe Indonesian Journal of Occupational Safety and Health, 2017
Safety sign is the equipment contained in the work environment in order to protect and enhance the awereness of workers against potential dangers which are occur in the work environment. This research was conducted to find out the suitability of applying
Febry Eka Saputra
doaj   +1 more source

Compliance in Filling Surgical Safety Checklist at The Central Surgical Installation

open access: yesJAI (Jurnal Anestesiologi Indonesia)
Background: One indicator to reduce unwanted events in the operating room is to implement the filling of the surgical safety checklist (SSC) sheet. Objective: The purpose of the study was to identify the level of compliance in filling SSC in the sign in,
Richa Noprianty   +2 more
doaj   +1 more source

The Impact of a Standardized Checklist on Transition of Care During Emergency Department Resident Physician Change of Shift

open access: yesWestern Journal of Emergency Medicine, 2019
Introduction: Transitions of patient care during physicians’ change of shift introduce the potential for critical information to be missed or distorted, resulting in possible morbidity. The Joint Commission, the Accreditation Council for Graduate Medical
Holly Stankewicz   +2 more
doaj   +1 more source

The ATIS sign language corpus [PDF]

open access: yes, 2008
Systems that automatically process sign language rely on appropriate data. We therefore present the ATIS sign language corpus that is based on the domain of air travel information. It is available for five languages, English, German, Irish sign language,
Morrissey, Sara   +6 more
core   +2 more sources

Teaching Video and Checklist: “Falling Through the Cracks: Year-End Resident Clinic Handoffs”

open access: yesMedEdPORTAL, 2012
Clinic handoffs affect a vast number of patients each year. Studies have demonstrated that these handoffs place patients at risk for poor outcomes and discontinuous care.
Amber T. Pincavage   +6 more
doaj   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

Guideline sign code, a format for the municipal regulation of on-premise signs [PDF]

open access: yes, 1981
Special funding to assist in the production and distribution of this publication was provided by the World Sign ...
National Electric Sign Association
core  

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy